Billionaires and Companies Investing Big in Longevity and Healthy Ageing Research
In recent years, there has been a surge of interest and investment in longevity research, with the aim of improving healthy ageing and extending the human lifespan. This movement sees participation from tech billionaires, biotech startups, and even entire countries committed to advancing our understanding of ageing and developing therapies to slow its biological effects.
The Rising Investment in Longevity Science
Although no current therapy can stop ageing or significantly extend maximum lifespan, cutting-edge research holds the promise of enabling people to remain healthier longer by slowing down some of the biological processes involved in ageing. This evolving field attracts significant funding and attention from private investors, large corporations, and government-backed initiatives globally.
Major Players Leading Longevity Research
Altos Labs: Cellular Rejuvenation Focus
Altos Labs, a US-based company, is one of the foremost names in longevity science, focusing on cellular rejuvenation and healthy ageing studies. It is backed by high-profile investors including Jeff Bezos and tech investor Yuri Milner, and aims to unlock the potential for reversing cell damage associated with ageing.
Calico and Alphabet’s Commitment
Calico, launched by Alphabet (Google’s parent company), collaborates with scientists and research institutions to address ageing and age-related diseases. Alphabet co-founder Larry Page is closely linked to the initiative, supporting long-term health and biology projects designed to improve lifespan quality.
Retro Biosciences: Extending Healthy Lifespan
Another key player is Retro Biosciences, focusing on interventions that may extend a healthy human lifespan. Backed by entrepreneur Sam Altman, the company represents the growing interest from technology innovators in longevity biotechnology.
Smaller Biotech Innovators in the Ageing Arena
- Unity Biotechnology: Targeting therapies to remove or repair ageing cells to improve tissue health.
- BioAge Labs: Utilizing AI and biomarkers to understand ageing pathways and develop new treatments.
- Insilico Medicine: Harnessing artificial intelligence for drug discovery, including therapies related to ageing.
- Life Biosciences: Studying cellular processes linked to ageing in the pursuit of effective therapies.
High-Profile Influencers and Their Initiatives
American entrepreneur Bryan Johnson has drawn international attention with his ‘Blueprint’ project, an extensive personal anti-ageing program involving tracking diet, sleep, exercise, and medical tests aimed at promoting long-term health and slowing biological ageing.
Investor Peter Thiel has also been a long-time supporter of longevity research, providing crucial funding to biotech and healthcare companies that explore anti-ageing solutions. Such investments help bring innovation and global focus to the sector.
Global Landscape: Countries Advancing Longevity Research
Several countries are actively expanding their investments and research capabilities in ageing science:
- United States: Remains the hub for biotech startups and progressive longevity research.
- Japan: Focuses heavily on ageing research due to its large elderly population.
- China: Increasing investment in biotechnology, AI-based medicine, and healthcare innovation.
- Saudi Arabia: Boosting investments through biotech-focused funds.
- Switzerland: A major centre for pharmaceutical and medical research.
- United Kingdom: Supports longevity through universities, biotech startups, and healthcare research programmes.
The Future of Longevity Research
While the quest to dramatically extend human lifespan is still ongoing, the advances being made in biology, medicine, and artificial intelligence hold great promise. Continued collaboration among investors, companies, and countries is essential for breakthroughs that could enable healthier ageing globally, transforming the way we understand longevity and quality of life.
